SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Electra Battery Materials Corp. engages in the refining, acquisition, and exploration of resource properties. Its project portfolio includes Iron Creek and Battery Materials Park. The company was founded on July 13, 2011 and is headquartered Toronto, Canada.

Electra Battery Materials Corp

Electra Battery Materials Corp is trending due to a recently secured $30 million financing deal and positive analyst ratings, potentially enabling the company to complete its cobalt refinery. The community is actively discussing the stock's momentum, potential for a short squeeze given the high borrowing fees, and its strategic positioning in the North American EV supply chain. Some see the stock as undervalued with significant upside potential, while others are wary of dilution and execution risks.

Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on June 30, 2023 and is headquartered in Dallas, TX.

Solidion Technology Inc

STI is trending due to excitement surrounding its new AI data-center UPS system, highlighting potential commercialization and significant order prospects. The community is focused on the low float and potential for a major squeeze, drawing comparisons to other high-momentum stocks in the clean energy and battery sectors. Discussions also include speculation about potential offerings and the company's long-term prospects in the rapidly growing AI infrastructure market.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining traction, with community members actively discussing its potential and strong mindshare, while also commenting on the recent market volatility. Some are highlighting its resilience, the strength of its community, and comparing it to other meme coins on the Solana blockchain. The project's website is being shared as a resource for those looking to learn more.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending as trade tensions with China escalate, spotlighting the importance of domestic antimony supply for national security and defense. Community members are discussing potential government investments and contracts, alongside the company's expansion plans. With China cutting off antimony exports, UAMY, a key U.S. producer, is gaining attention, fueling speculation of significant growth.

Microvast Holdings, Inc. is an advanced battery technology company. It engages in the business of designing, developing, and manufacturing battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems. The company was founded by Yang Wu on October 12, 2006 and is headquartered in Stafford, TX.

Microvast Holdings Inc

Microvast ($MVST) is trending as the community discusses its potential for significant growth, highlighting its small float, low short interest, and progress in EU revenues. Some believe the stock is undervalued compared to competitors like $QS and are anticipating a substantial move towards higher valuations, possibly reaching three-digit figures long term. Bullish sentiment is fueled by positive technical indicators and upcoming Q3 earnings, with some eyeing a potential short squeeze.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies behind the OG meme coin, emphasizing its resilience amid market volatility. Discussions highlight the strength of the community, with many expressing bullish sentiment and encouraging others to embrace the 'rage' and 'send it' to new heights. The return of rage comics and memetic energy are central to the current conversation.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as shares trade higher following the announcement of a partnership with Tsecond to deliver AI-enabled edge infrastructure. The community is buzzing with excitement, anticipating a potential short squeeze and further upside, with some eyeing double-digit prices soon. Discussions also include the company's strong backlog and cash position, fueling speculation about upcoming government contracts.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending as traders discuss its potential link to NVDA and the broader AI sector, with some speculating about a possible acquisition or partnership. Community members are closely watching volume and order flow, anticipating a potential squeeze and further upside. Some are also pointing to the company's shift in GaN orders and its potential impact on future revenue.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its resilience during a recent crypto market event where it maintained high transaction speeds while other networks faltered.  The launch of CFTC-regulated $SOL options trading on CME Group is also fueling interest.  Traders are actively watching meme coins on Solana, with some suggesting it remains undervalued.

ESS Tech, Inc. is a long-duration energy storage company, which specializes in iron flow battery technology. It develops long duration iron flow batteries for commercial and utility-scale energy storage applications requiring four or more hours of flexible energy capacity predominantly using earth-abundant materials. The company was founded by Julia Song and Craig E. Evans in January 2011 and is headquartered in Wilsonville, OR.

ESS Tech Inc

GWH is trending due to a recent utility-scale battery deal and potential benefits from China's new export license requirements. The community is actively discussing the stock's high trading volume, potential short squeeze, and comparing it to other recent runners. Some investors are highlighting institutional ownership and potential for further gains, while others are wary of potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $53.96, signifying a -7.36% move from its prior day's close.

Hims & Hers Expands Personalized Care Access Via Telehealth Platform

HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctors Office

Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous...

Meme stock mania 2.0

GameStop and AMC were the early faces of the meme stock revolution as retail investors traded these shares in a viral frenzy even if there wasn't factual news. Famously, investor Roaring Kitty, also...

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know  

Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Hims & Hers Expands Health Access Through Subscription Revenue Model

HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL vs. HIMS: Which Stock Is the Better Value Option?

Eli Lilly's stock jumped over 5% on Tuesday after U.S.President Donald Trump unveiled a plan to lower U.S. drug prices, which included a “TrumpRx” direct-to-consumer website and a pricing agreement with Pfizer.&nbsp;Pfizer became the first company to accept the administration’s terms, agreeing to slash drug prices by up to 85% and secure a three-year exemption from pharmaceutical tariffs.BMO Capital Markets analyst Evan Seigerman said the Pfizer deal effectively provided a model for other drugmakers such as Eli Lilly to balance pricing cooperation with policy compliance. He said the structure gave the administration a political win while avoiding the need for harsher price controls or new tariffs, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-30/pfizer-to-cut-medicaid-drug-prices-in-deal-with-trump-wapo">report</a>.Cantor analyst Carter Gould said the sharp rally in pharmaceutical shares reflected investor relief that the policy measures were more symbolic than financially disruptive. He noted that Pfizer’s announcement did not change any earnings guidance, suggesting that the market viewed the move as a sign of easing regulatory uncertainty rather than a fundamental earnings risk.The S&amp;P 500 Pharmaceuticals Index rose nearly 4%, while Lilly recorded its best day in more than a month. Pfizer climbed nearly 7%, marking its strongest single-day gain in almost four years.Raymond James health policy analyst Chris Meekins said the TrumpRx program was unlikely to materially affect consumers’ costs unless insurance reforms followed. He said that if the administration’s pricing actions stopped at this stage, it would amount to a win for the pharmaceutical industry, CNN&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/2025/09/30/politics/pfizer-drug-prices-trump">noted</a>.Meanwhile, Futurum Equities chief market strategist Shay Baloor&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/StockSavvyShay/status/1973057650150764638">wrote on X</a> that Trump’s agreement with Pfizer to launch TrumpRx, which allows consumers to buy discounted medications directly from manufacturers, could hurt insurers and pharmacy benefit managers.&nbsp;Baloor viewed companies such as Eli Lilly, UnitedHealth, Cigna, and Walgreens as potential losers from the shift, while naming Hims &amp; Hers Health among the likely beneficiaries.Eli Lilly stated that it was in active discussions with the administration to expand patient access, signaling its readiness to participate in broader efforts to increase affordability. The statement followed Trump’s call for drugmakers to align U.S. prices with international levels under his “Most Favored Nation” directive.Commerce Secretary Howard Lutnick said negotiations with major drugmakers were ongoing, while Trump described the plan as a step toward ending what he called global price disparities in medicine.Eli Lilly has not disclosed details of its discussions but said it remains focused on expanding access and improving affordability for patients in the U.S..On Stocktwits, retail sentiment was ‘bullish’ for Eli Lilly and ‘extremely bullish’ for Pfizer, with 24-hour message volumes surging 191% and 780%, respectively.<figure class="image"><img style="aspect-ratio:618/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_30_at_10_14_21_PM_png_d8474c8869.webp" alt="Screenshot 2025-09-30 at 10.14.21 PM.png" width="618" height="55"><figcaption>LLY sentiment and message volume as of 10:15 p.m. ET, Sept. 30 | source: Stocktwits</figcaption></figure>One user noted that the new TrumpRx model, which eliminates middlemen, is unlikely to impact margins for companies such as Eli Lilly, Merck, and Pfizer, describing it as a direct-to-consumer shift.&nbsp;<stembedurl>https://stocktwits.com/Jessdog77/message/630503208</stembedurl>Another user described Eli Lilly as a strong performer that continues to show unstoppable momentum.<stembedurl>https://stocktwits.com/Stonkapedia/message/630566985</stembedurl><a href="https://stocktwits.com/symbol/LLY">Eli Lilly’s stock</a> has declined 0.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/nike-retail-investors-turn-more-bullish-as-q1-performance-confirms-turnaround-progress-good-report-in-difficult-market/chCooXAR39N">Nike Retail Investors Turn More Bullish As Q1 Performance Confirms Turnaround Progress: 'Good Report In Difficult Market'</a>

The entrance to the Eli Lilly factory in Kinsale, Co Cork, where weight loss drug Mounjaro is made. Picture date: Sunday May 18, 2025.

Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma

Analysts said the plan signals a political win that could reshape how major drugmakers engage with U.S. policymakers.

Equity

Analysts said the plan signals a political win that could reshape how major drugmakers engage with U.S. policymakers.


Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why

The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $59.12, representing a +1.23% change from its previous close.

HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?

Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$54.68
Prev Close	$53.95
Open	$54.35
Dividend Yield	0.00%
50-Day Moving Average	$51.26
Beta	1.93
Avg. Volume	28.99M
PE Ratio	67.52

52-Week High	$72.98
52-Week Low	$18.33
Market Capitalization	$12.19B
EPS (Annual)	$0.5322
Price to Book	21.65
Revenue Per Employee	$901,963.35
Enterprise Value/EBITDA	N/A

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HIMS News

HIMSHims & Hers Health Inc